nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—epilepsy syndrome	0.611	1	CbGaD
Pemetrexed—ATIC—forelimb—epilepsy syndrome	0.00704	0.112	CbGeAlD
Pemetrexed—ATIC—ganglion—epilepsy syndrome	0.0038	0.0604	CbGeAlD
Pemetrexed—GART—forebrain—epilepsy syndrome	0.00235	0.0373	CbGeAlD
Pemetrexed—GART—telencephalon—epilepsy syndrome	0.00216	0.0343	CbGeAlD
Pemetrexed—GART—medulla oblongata—epilepsy syndrome	0.0017	0.0269	CbGeAlD
Pemetrexed—ATIC—brainstem—epilepsy syndrome	0.00165	0.0262	CbGeAlD
Pemetrexed—ATIC—forebrain—epilepsy syndrome	0.00159	0.0253	CbGeAlD
Pemetrexed—GART—midbrain—epilepsy syndrome	0.00155	0.0246	CbGeAlD
Pemetrexed—GART—spinal cord—epilepsy syndrome	0.00151	0.024	CbGeAlD
Pemetrexed—ATIC—telencephalon—epilepsy syndrome	0.00147	0.0233	CbGeAlD
Pemetrexed—GART—head—epilepsy syndrome	0.00134	0.0214	CbGeAlD
Pemetrexed—Tetrahydrofolic acid—ATIC—epilepsy syndrome	0.00129	0.255	CrCbGaD
Pemetrexed—GART—nervous system—epilepsy syndrome	0.00127	0.0202	CbGeAlD
Pemetrexed—SLC46A1—spinal cord—epilepsy syndrome	0.00123	0.0195	CbGeAlD
Pemetrexed—GART—central nervous system—epilepsy syndrome	0.00123	0.0195	CbGeAlD
Pemetrexed—GART—cerebellum—epilepsy syndrome	0.0012	0.0191	CbGeAlD
Pemetrexed—Methotrexate—FOLR1—epilepsy syndrome	0.00116	0.23	CrCbGaD
Pemetrexed—TYMS—L-Glutamine—Vigabatrin—epilepsy syndrome	0.00113	0.352	CbGdCrCtD
Pemetrexed—SLC46A1—head—epilepsy syndrome	0.00109	0.0173	CbGeAlD
Pemetrexed—ATIC—midbrain—epilepsy syndrome	0.00105	0.0167	CbGeAlD
Pemetrexed—SLC46A1—nervous system—epilepsy syndrome	0.00103	0.0164	CbGeAlD
Pemetrexed—ATIC—spinal cord—epilepsy syndrome	0.00103	0.0163	CbGeAlD
Pemetrexed—SLC46A1—central nervous system—epilepsy syndrome	0.000996	0.0158	CbGeAlD
Pemetrexed—TYMS—telencephalon—epilepsy syndrome	0.000995	0.0158	CbGeAlD
Pemetrexed—DHFR—telencephalon—epilepsy syndrome	0.000985	0.0156	CbGeAlD
Pemetrexed—GART—brain—epilepsy syndrome	0.000975	0.0155	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—epilepsy syndrome	0.000974	0.0155	CbGeAlD
Pemetrexed—SLC29A1—forebrain—epilepsy syndrome	0.00097	0.0154	CbGeAlD
Pemetrexed—ATIC—head—epilepsy syndrome	0.000913	0.0145	CbGeAlD
Pemetrexed—SLC29A1—telencephalon—epilepsy syndrome	0.000892	0.0142	CbGeAlD
Pemetrexed—Methotrexate—ATIC—epilepsy syndrome	0.000882	0.174	CrCbGaD
Pemetrexed—ATIC—nervous system—epilepsy syndrome	0.000866	0.0137	CbGeAlD
Pemetrexed—DCK—telencephalon—epilepsy syndrome	0.000852	0.0135	CbGeAlD
Pemetrexed—ATIC—central nervous system—epilepsy syndrome	0.000834	0.0132	CbGeAlD
Pemetrexed—ATIC—cerebellum—epilepsy syndrome	0.000815	0.0129	CbGeAlD
Pemetrexed—SLC46A1—brain—epilepsy syndrome	0.000791	0.0126	CbGeAlD
Pemetrexed—DHFR—medulla oblongata—epilepsy syndrome	0.000774	0.0123	CbGeAlD
Pemetrexed—DHFR—Niclosamide—Clonazepam—epilepsy syndrome	0.000767	0.24	CbGdCrCtD
Pemetrexed—TYMS—midbrain—epilepsy syndrome	0.000714	0.0113	CbGeAlD
Pemetrexed—DHFR—midbrain—epilepsy syndrome	0.000707	0.0112	CbGeAlD
Pemetrexed—DHFR—spinal cord—epilepsy syndrome	0.00069	0.011	CbGeAlD
Pemetrexed—DCK—medulla oblongata—epilepsy syndrome	0.000669	0.0106	CbGeAlD
Pemetrexed—ATIC—brain—epilepsy syndrome	0.000662	0.0105	CbGeAlD
Pemetrexed—TYMS—head—epilepsy syndrome	0.000619	0.00984	CbGeAlD
Pemetrexed—DHFR—head—epilepsy syndrome	0.000613	0.00974	CbGeAlD
Pemetrexed—DCK—midbrain—epilepsy syndrome	0.000612	0.00972	CbGeAlD
Pemetrexed—DCK—spinal cord—epilepsy syndrome	0.000597	0.00948	CbGeAlD
Pemetrexed—TYMS—nervous system—epilepsy syndrome	0.000587	0.00932	CbGeAlD
Pemetrexed—DHFR—nervous system—epilepsy syndrome	0.000581	0.00923	CbGeAlD
Pemetrexed—TYMS—central nervous system—epilepsy syndrome	0.000565	0.00898	CbGeAlD
Pemetrexed—DHFR—central nervous system—epilepsy syndrome	0.00056	0.00889	CbGeAlD
Pemetrexed—SLC29A1—head—epilepsy syndrome	0.000555	0.00882	CbGeAlD
Pemetrexed—TYMS—cerebellum—epilepsy syndrome	0.000553	0.00877	CbGeAlD
Pemetrexed—DHFR—cerebellum—epilepsy syndrome	0.000547	0.00869	CbGeAlD
Pemetrexed—DCK—head—epilepsy syndrome	0.000531	0.00843	CbGeAlD
Pemetrexed—SLC29A1—nervous system—epilepsy syndrome	0.000527	0.00836	CbGeAlD
Pemetrexed—SLC29A1—central nervous system—epilepsy syndrome	0.000507	0.00805	CbGeAlD
Pemetrexed—DCK—nervous system—epilepsy syndrome	0.000503	0.00799	CbGeAlD
Pemetrexed—SLC29A1—cerebellum—epilepsy syndrome	0.000495	0.00787	CbGeAlD
Pemetrexed—DCK—central nervous system—epilepsy syndrome	0.000484	0.00769	CbGeAlD
Pemetrexed—DCK—cerebellum—epilepsy syndrome	0.000473	0.00752	CbGeAlD
Pemetrexed—TYMS—brain—epilepsy syndrome	0.000449	0.00713	CbGeAlD
Pemetrexed—DHFR—brain—epilepsy syndrome	0.000444	0.00706	CbGeAlD
Pemetrexed—SLC29A1—brain—epilepsy syndrome	0.000402	0.00639	CbGeAlD
Pemetrexed—Leucovorin—ABCC2—epilepsy syndrome	0.0004	0.0792	CrCbGaD
Pemetrexed—DCK—brain—epilepsy syndrome	0.000384	0.00611	CbGeAlD
Pemetrexed—Methotrexate—SLCO1A2—epilepsy syndrome	0.000369	0.073	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—ABCC2—epilepsy syndrome	0.000258	0.051	CrCbGaD
Pemetrexed—TYMS—Bortezomib—Lacosamide—epilepsy syndrome	0.000235	0.0737	CbGdCrCtD
Pemetrexed—Folic Acid—ABCG2—epilepsy syndrome	0.000228	0.0451	CrCbGaD
Pemetrexed—DCK—Niclosamide—Clonazepam—epilepsy syndrome	0.000217	0.0678	CbGdCrCtD
Pemetrexed—TYMS—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.000216	0.0677	CbGdCrCtD
Pemetrexed—Methotrexate—ABCC2—epilepsy syndrome	0.000176	0.0349	CrCbGaD
Pemetrexed—TYMS—Chlorprothixene—Midazolam—epilepsy syndrome	0.000175	0.0547	CbGdCrCtD
Pemetrexed—TYMS—Niclosamide—Clonazepam—epilepsy syndrome	0.000163	0.0511	CbGdCrCtD
Pemetrexed—Methotrexate—ABCG2—epilepsy syndrome	0.000156	0.0309	CrCbGaD
Pemetrexed—TYMS—Chlorprothixene—Diazepam—epilepsy syndrome	0.000156	0.0488	CbGdCrCtD
Pemetrexed—TYMS—Chlorpromazine—Clobazam—epilepsy syndrome	0.00014	0.0438	CbGdCrCtD
Pemetrexed—Chest pain—Valproic Acid—epilepsy syndrome	8.89e-05	0.000483	CcSEcCtD
Pemetrexed—Arthralgia—Valproic Acid—epilepsy syndrome	8.89e-05	0.000483	CcSEcCtD
Pemetrexed—Myalgia—Valproic Acid—epilepsy syndrome	8.89e-05	0.000483	CcSEcCtD
Pemetrexed—Rash—Midazolam—epilepsy syndrome	8.84e-05	0.00048	CcSEcCtD
Pemetrexed—Dizziness—Fosphenytoin—epilepsy syndrome	8.84e-05	0.000479	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.83e-05	0.000479	CcSEcCtD
Pemetrexed—Dermatitis—Midazolam—epilepsy syndrome	8.83e-05	0.000479	CcSEcCtD
Pemetrexed—Urticaria—Carbamazepine—epilepsy syndrome	8.82e-05	0.000479	CcSEcCtD
Pemetrexed—Vomiting—Levetiracetam—epilepsy syndrome	8.8e-05	0.000478	CcSEcCtD
Pemetrexed—Alopecia—Gabapentin—epilepsy syndrome	8.79e-05	0.000477	CcSEcCtD
Pemetrexed—Pruritus—Felbamate—epilepsy syndrome	8.78e-05	0.000476	CcSEcCtD
Pemetrexed—Abdominal pain—Carbamazepine—epilepsy syndrome	8.77e-05	0.000476	CcSEcCtD
Pemetrexed—Body temperature increased—Carbamazepine—epilepsy syndrome	8.77e-05	0.000476	CcSEcCtD
Pemetrexed—Diarrhoea—Diazepam—epilepsy syndrome	8.77e-05	0.000476	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.77e-05	0.000476	CcSEcCtD
Pemetrexed—Rash—Levetiracetam—epilepsy syndrome	8.73e-05	0.000474	CcSEcCtD
Pemetrexed—Anaemia—Pregabalin—epilepsy syndrome	8.73e-05	0.000474	CcSEcCtD
Pemetrexed—Dermatitis—Levetiracetam—epilepsy syndrome	8.72e-05	0.000473	CcSEcCtD
Pemetrexed—Asthenia—Zonisamide—epilepsy syndrome	8.72e-05	0.000473	CcSEcCtD
Pemetrexed—Agranulocytosis—Topiramate—epilepsy syndrome	8.7e-05	0.000472	CcSEcCtD
Pemetrexed—Erythema—Gabapentin—epilepsy syndrome	8.66e-05	0.00047	CcSEcCtD
Pemetrexed—Malnutrition—Gabapentin—epilepsy syndrome	8.66e-05	0.00047	CcSEcCtD
Pemetrexed—Hypersensitivity—Clonazepam—epilepsy syndrome	8.63e-05	0.000468	CcSEcCtD
Pemetrexed—Dizziness—Vigabatrin—epilepsy syndrome	8.61e-05	0.000467	CcSEcCtD
Pemetrexed—Pruritus—Zonisamide—epilepsy syndrome	8.59e-05	0.000466	CcSEcCtD
Pemetrexed—Hypersensitivity—Phenytoin—epilepsy syndrome	8.57e-05	0.000465	CcSEcCtD
Pemetrexed—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.52e-05	0.000463	CcSEcCtD
Pemetrexed—Oedema—Valproic Acid—epilepsy syndrome	8.52e-05	0.000463	CcSEcCtD
Pemetrexed—Urticaria—Lamotrigine—epilepsy syndrome	8.52e-05	0.000462	CcSEcCtD
Pemetrexed—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.52e-05	0.000462	CcSEcCtD
Pemetrexed—Nausea—Propofol—epilepsy syndrome	8.51e-05	0.000462	CcSEcCtD
Pemetrexed—Vomiting—Fosphenytoin—epilepsy syndrome	8.5e-05	0.000461	CcSEcCtD
Pemetrexed—Diarrhoea—Felbamate—epilepsy syndrome	8.49e-05	0.000461	CcSEcCtD
Pemetrexed—Body temperature increased—Lamotrigine—epilepsy syndrome	8.48e-05	0.00046	CcSEcCtD
Pemetrexed—Abdominal pain—Lamotrigine—epilepsy syndrome	8.48e-05	0.00046	CcSEcCtD
Pemetrexed—Dysgeusia—Gabapentin—epilepsy syndrome	8.48e-05	0.00046	CcSEcCtD
Pemetrexed—Dizziness—Diazepam—epilepsy syndrome	8.48e-05	0.00046	CcSEcCtD
Pemetrexed—Infection—Valproic Acid—epilepsy syndrome	8.47e-05	0.00046	CcSEcCtD
Pemetrexed—Syncope—Pregabalin—epilepsy syndrome	8.47e-05	0.00046	CcSEcCtD
Pemetrexed—Leukopenia—Pregabalin—epilepsy syndrome	8.45e-05	0.000459	CcSEcCtD
Pemetrexed—Rash—Fosphenytoin—epilepsy syndrome	8.42e-05	0.000457	CcSEcCtD
Pemetrexed—Dermatitis—Fosphenytoin—epilepsy syndrome	8.42e-05	0.000457	CcSEcCtD
Pemetrexed—Asthenia—Clonazepam—epilepsy syndrome	8.4e-05	0.000456	CcSEcCtD
Pemetrexed—Hepatitis—Topiramate—epilepsy syndrome	8.37e-05	0.000454	CcSEcCtD
Pemetrexed—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.36e-05	0.000454	CcSEcCtD
Pemetrexed—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.35e-05	0.000453	CcSEcCtD
Pemetrexed—Asthenia—Phenytoin—epilepsy syndrome	8.34e-05	0.000453	CcSEcCtD
Pemetrexed—Nausea—Midazolam—epilepsy syndrome	8.33e-05	0.000452	CcSEcCtD
Pemetrexed—Diarrhoea—Zonisamide—epilepsy syndrome	8.31e-05	0.000451	CcSEcCtD
Pemetrexed—Pharyngitis—Topiramate—epilepsy syndrome	8.31e-05	0.000451	CcSEcCtD
Pemetrexed—Loss of consciousness—Pregabalin—epilepsy syndrome	8.3e-05	0.00045	CcSEcCtD
Pemetrexed—Asthenia—Oxcarbazepine—epilepsy syndrome	8.3e-05	0.00045	CcSEcCtD
Pemetrexed—Pruritus—Clonazepam—epilepsy syndrome	8.28e-05	0.000449	CcSEcCtD
Pemetrexed—Vomiting—Vigabatrin—epilepsy syndrome	8.28e-05	0.000449	CcSEcCtD
Pemetrexed—Skin disorder—Valproic Acid—epilepsy syndrome	8.28e-05	0.000449	CcSEcCtD
Pemetrexed—Urinary tract disorder—Topiramate—epilepsy syndrome	8.26e-05	0.000448	CcSEcCtD
Pemetrexed—Pruritus—Phenytoin—epilepsy syndrome	8.23e-05	0.000446	CcSEcCtD
Pemetrexed—Nausea—Levetiracetam—epilepsy syndrome	8.22e-05	0.000446	CcSEcCtD
Pemetrexed—Rash—Vigabatrin—epilepsy syndrome	8.21e-05	0.000446	CcSEcCtD
Pemetrexed—Dizziness—Felbamate—epilepsy syndrome	8.21e-05	0.000445	CcSEcCtD
Pemetrexed—Dermatitis—Vigabatrin—epilepsy syndrome	8.2e-05	0.000445	CcSEcCtD
Pemetrexed—Urethral disorder—Topiramate—epilepsy syndrome	8.2e-05	0.000445	CcSEcCtD
Pemetrexed—Pruritus—Oxcarbazepine—epilepsy syndrome	8.18e-05	0.000444	CcSEcCtD
Pemetrexed—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.18e-05	0.000444	CcSEcCtD
Pemetrexed—Hypertension—Pregabalin—epilepsy syndrome	8.15e-05	0.000442	CcSEcCtD
Pemetrexed—Vomiting—Diazepam—epilepsy syndrome	8.15e-05	0.000442	CcSEcCtD
Pemetrexed—Anorexia—Valproic Acid—epilepsy syndrome	8.13e-05	0.000441	CcSEcCtD
Pemetrexed—Rash—Diazepam—epilepsy syndrome	8.08e-05	0.000439	CcSEcCtD
Pemetrexed—Dermatitis—Diazepam—epilepsy syndrome	8.08e-05	0.000438	CcSEcCtD
Pemetrexed—Arthralgia—Pregabalin—epilepsy syndrome	8.04e-05	0.000436	CcSEcCtD
Pemetrexed—Chest pain—Pregabalin—epilepsy syndrome	8.04e-05	0.000436	CcSEcCtD
Pemetrexed—Myalgia—Pregabalin—epilepsy syndrome	8.04e-05	0.000436	CcSEcCtD
Pemetrexed—Dizziness—Zonisamide—epilepsy syndrome	8.03e-05	0.000436	CcSEcCtD
Pemetrexed—Diarrhoea—Clonazepam—epilepsy syndrome	8.01e-05	0.000435	CcSEcCtD
Pemetrexed—Anaemia—Gabapentin—epilepsy syndrome	8e-05	0.000434	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.98e-05	0.000433	CcSEcCtD
Pemetrexed—Asthenia—Carbamazepine—epilepsy syndrome	7.96e-05	0.000432	CcSEcCtD
Pemetrexed—Diarrhoea—Phenytoin—epilepsy syndrome	7.96e-05	0.000432	CcSEcCtD
Pemetrexed—Nausea—Fosphenytoin—epilepsy syndrome	7.94e-05	0.000431	CcSEcCtD
Pemetrexed—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000429	CcSEcCtD
Pemetrexed—Erythema multiforme—Topiramate—epilepsy syndrome	7.91e-05	0.000429	CcSEcCtD
Pemetrexed—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.9e-05	0.000429	CcSEcCtD
Pemetrexed—Vomiting—Felbamate—epilepsy syndrome	7.89e-05	0.000428	CcSEcCtD
Pemetrexed—Pruritus—Carbamazepine—epilepsy syndrome	7.85e-05	0.000426	CcSEcCtD
Pemetrexed—Rash—Felbamate—epilepsy syndrome	7.82e-05	0.000425	CcSEcCtD
Pemetrexed—Eye disorder—Topiramate—epilepsy syndrome	7.82e-05	0.000424	CcSEcCtD
Pemetrexed—Dermatitis—Felbamate—epilepsy syndrome	7.82e-05	0.000424	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.77e-05	0.000421	CcSEcCtD
Pemetrexed—Syncope—Gabapentin—epilepsy syndrome	7.77e-05	0.000421	CcSEcCtD
Pemetrexed—Leukopenia—Gabapentin—epilepsy syndrome	7.75e-05	0.000421	CcSEcCtD
Pemetrexed—Dizziness—Clonazepam—epilepsy syndrome	7.74e-05	0.00042	CcSEcCtD
Pemetrexed—Nausea—Vigabatrin—epilepsy syndrome	7.74e-05	0.00042	CcSEcCtD
Pemetrexed—Vomiting—Zonisamide—epilepsy syndrome	7.72e-05	0.000419	CcSEcCtD
Pemetrexed—Oedema—Pregabalin—epilepsy syndrome	7.71e-05	0.000418	CcSEcCtD
Pemetrexed—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.71e-05	0.000418	CcSEcCtD
Pemetrexed—Asthenia—Lamotrigine—epilepsy syndrome	7.7e-05	0.000418	CcSEcCtD
Pemetrexed—Dizziness—Phenytoin—epilepsy syndrome	7.69e-05	0.000417	CcSEcCtD
Pemetrexed—Rash—Zonisamide—epilepsy syndrome	7.66e-05	0.000416	CcSEcCtD
Pemetrexed—Infection—Pregabalin—epilepsy syndrome	7.66e-05	0.000415	CcSEcCtD
Pemetrexed—Dermatitis—Zonisamide—epilepsy syndrome	7.65e-05	0.000415	CcSEcCtD
Pemetrexed—Dizziness—Oxcarbazepine—epilepsy syndrome	7.65e-05	0.000415	CcSEcCtD
Pemetrexed—Nausea—Diazepam—epilepsy syndrome	7.62e-05	0.000413	CcSEcCtD
Pemetrexed—Loss of consciousness—Gabapentin—epilepsy syndrome	7.61e-05	0.000413	CcSEcCtD
Pemetrexed—Dyspnoea—Valproic Acid—epilepsy syndrome	7.6e-05	0.000412	CcSEcCtD
Pemetrexed—Diarrhoea—Carbamazepine—epilepsy syndrome	7.59e-05	0.000412	CcSEcCtD
Pemetrexed—Pruritus—Lamotrigine—epilepsy syndrome	7.59e-05	0.000412	CcSEcCtD
Pemetrexed—Shock—Pregabalin—epilepsy syndrome	7.58e-05	0.000411	CcSEcCtD
Pemetrexed—Nervous system disorder—Pregabalin—epilepsy syndrome	7.56e-05	0.00041	CcSEcCtD
Pemetrexed—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.55e-05	0.000409	CcSEcCtD
Pemetrexed—Dyspepsia—Valproic Acid—epilepsy syndrome	7.5e-05	0.000407	CcSEcCtD
Pemetrexed—Skin disorder—Pregabalin—epilepsy syndrome	7.49e-05	0.000406	CcSEcCtD
Pemetrexed—Hypertension—Gabapentin—epilepsy syndrome	7.48e-05	0.000406	CcSEcCtD
Pemetrexed—Vomiting—Clonazepam—epilepsy syndrome	7.44e-05	0.000404	CcSEcCtD
Pemetrexed—Decreased appetite—Valproic Acid—epilepsy syndrome	7.41e-05	0.000402	CcSEcCtD
Pemetrexed—Alopecia—Topiramate—epilepsy syndrome	7.4e-05	0.000401	CcSEcCtD
Pemetrexed—Vomiting—Phenytoin—epilepsy syndrome	7.39e-05	0.000401	CcSEcCtD
Pemetrexed—Rash—Clonazepam—epilepsy syndrome	7.38e-05	0.000401	CcSEcCtD
Pemetrexed—Dermatitis—Clonazepam—epilepsy syndrome	7.37e-05	0.0004	CcSEcCtD
Pemetrexed—Myalgia—Gabapentin—epilepsy syndrome	7.37e-05	0.0004	CcSEcCtD
Pemetrexed—Arthralgia—Gabapentin—epilepsy syndrome	7.37e-05	0.0004	CcSEcCtD
Pemetrexed—Chest pain—Gabapentin—epilepsy syndrome	7.37e-05	0.0004	CcSEcCtD
Pemetrexed—Nausea—Felbamate—epilepsy syndrome	7.37e-05	0.0004	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.36e-05	0.000399	CcSEcCtD
Pemetrexed—Vomiting—Oxcarbazepine—epilepsy syndrome	7.35e-05	0.000399	CcSEcCtD
Pemetrexed—Fatigue—Valproic Acid—epilepsy syndrome	7.35e-05	0.000399	CcSEcCtD
Pemetrexed—Anorexia—Pregabalin—epilepsy syndrome	7.35e-05	0.000399	CcSEcCtD
Pemetrexed—Dizziness—Carbamazepine—epilepsy syndrome	7.34e-05	0.000398	CcSEcCtD
Pemetrexed—Diarrhoea—Lamotrigine—epilepsy syndrome	7.34e-05	0.000398	CcSEcCtD
Pemetrexed—Rash—Phenytoin—epilepsy syndrome	7.33e-05	0.000398	CcSEcCtD
Pemetrexed—Dermatitis—Phenytoin—epilepsy syndrome	7.33e-05	0.000398	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.32e-05	0.000397	CcSEcCtD
Pemetrexed—Rash—Oxcarbazepine—epilepsy syndrome	7.29e-05	0.000396	CcSEcCtD
Pemetrexed—Pain—Valproic Acid—epilepsy syndrome	7.29e-05	0.000396	CcSEcCtD
Pemetrexed—Constipation—Valproic Acid—epilepsy syndrome	7.29e-05	0.000396	CcSEcCtD
Pemetrexed—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.29e-05	0.000395	CcSEcCtD
Pemetrexed—Malnutrition—Topiramate—epilepsy syndrome	7.28e-05	0.000395	CcSEcCtD
Pemetrexed—Erythema—Topiramate—epilepsy syndrome	7.28e-05	0.000395	CcSEcCtD
Pemetrexed—Nausea—Zonisamide—epilepsy syndrome	7.22e-05	0.000392	CcSEcCtD
Pemetrexed—Dysgeusia—Topiramate—epilepsy syndrome	7.13e-05	0.000387	CcSEcCtD
Pemetrexed—Dizziness—Lamotrigine—epilepsy syndrome	7.09e-05	0.000385	CcSEcCtD
Pemetrexed—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.07e-05	0.000384	CcSEcCtD
Pemetrexed—Oedema—Gabapentin—epilepsy syndrome	7.07e-05	0.000384	CcSEcCtD
Pemetrexed—Vomiting—Carbamazepine—epilepsy syndrome	7.06e-05	0.000383	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.02e-05	0.000381	CcSEcCtD
Pemetrexed—Infection—Gabapentin—epilepsy syndrome	7.02e-05	0.000381	CcSEcCtD
Pemetrexed—Rash—Carbamazepine—epilepsy syndrome	7e-05	0.00038	CcSEcCtD
Pemetrexed—Dermatitis—Carbamazepine—epilepsy syndrome	6.99e-05	0.000379	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.97e-05	0.000378	CcSEcCtD
Pemetrexed—Nausea—Clonazepam—epilepsy syndrome	6.95e-05	0.000377	CcSEcCtD
Pemetrexed—Shock—Gabapentin—epilepsy syndrome	6.95e-05	0.000377	CcSEcCtD
Pemetrexed—Nervous system disorder—Gabapentin—epilepsy syndrome	6.93e-05	0.000376	CcSEcCtD
Pemetrexed—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.92e-05	0.000375	CcSEcCtD
Pemetrexed—Nausea—Phenytoin—epilepsy syndrome	6.91e-05	0.000375	CcSEcCtD
Pemetrexed—Dyspnoea—Pregabalin—epilepsy syndrome	6.87e-05	0.000373	CcSEcCtD
Pemetrexed—Nausea—Oxcarbazepine—epilepsy syndrome	6.87e-05	0.000373	CcSEcCtD
Pemetrexed—Skin disorder—Gabapentin—epilepsy syndrome	6.86e-05	0.000373	CcSEcCtD
Pemetrexed—Vomiting—Lamotrigine—epilepsy syndrome	6.82e-05	0.00037	CcSEcCtD
Pemetrexed—Methotrexate—ALB—epilepsy syndrome	6.8e-05	0.0135	CrCbGaD
Pemetrexed—Urticaria—Valproic Acid—epilepsy syndrome	6.77e-05	0.000368	CcSEcCtD
Pemetrexed—Rash—Lamotrigine—epilepsy syndrome	6.76e-05	0.000367	CcSEcCtD
Pemetrexed—Dermatitis—Lamotrigine—epilepsy syndrome	6.76e-05	0.000367	CcSEcCtD
Pemetrexed—Abdominal pain—Valproic Acid—epilepsy syndrome	6.74e-05	0.000366	CcSEcCtD
Pemetrexed—Body temperature increased—Valproic Acid—epilepsy syndrome	6.74e-05	0.000366	CcSEcCtD
Pemetrexed—Anorexia—Gabapentin—epilepsy syndrome	6.74e-05	0.000366	CcSEcCtD
Pemetrexed—Anaemia—Topiramate—epilepsy syndrome	6.73e-05	0.000365	CcSEcCtD
Pemetrexed—Decreased appetite—Pregabalin—epilepsy syndrome	6.7e-05	0.000364	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.65e-05	0.000361	CcSEcCtD
Pemetrexed—Fatigue—Pregabalin—epilepsy syndrome	6.64e-05	0.000361	CcSEcCtD
Pemetrexed—Nausea—Carbamazepine—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Pemetrexed—Constipation—Pregabalin—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Pemetrexed—Pain—Pregabalin—epilepsy syndrome	6.59e-05	0.000358	CcSEcCtD
Pemetrexed—Syncope—Topiramate—epilepsy syndrome	6.53e-05	0.000355	CcSEcCtD
Pemetrexed—Leukopenia—Topiramate—epilepsy syndrome	6.52e-05	0.000354	CcSEcCtD
Pemetrexed—Methotrexate—ABCB1—epilepsy syndrome	6.49e-05	0.0128	CrCbGaD
Pemetrexed—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.44e-05	0.000349	CcSEcCtD
Pemetrexed—Loss of consciousness—Topiramate—epilepsy syndrome	6.4e-05	0.000347	CcSEcCtD
Pemetrexed—Nausea—Lamotrigine—epilepsy syndrome	6.37e-05	0.000346	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.3e-05	0.000342	CcSEcCtD
Pemetrexed—Dyspnoea—Gabapentin—epilepsy syndrome	6.3e-05	0.000342	CcSEcCtD
Pemetrexed—Hypertension—Topiramate—epilepsy syndrome	6.29e-05	0.000341	CcSEcCtD
Pemetrexed—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.28e-05	0.000341	CcSEcCtD
Pemetrexed—Dyspepsia—Gabapentin—epilepsy syndrome	6.22e-05	0.000338	CcSEcCtD
Pemetrexed—Myalgia—Topiramate—epilepsy syndrome	6.2e-05	0.000337	CcSEcCtD
Pemetrexed—Chest pain—Topiramate—epilepsy syndrome	6.2e-05	0.000337	CcSEcCtD
Pemetrexed—Arthralgia—Topiramate—epilepsy syndrome	6.2e-05	0.000337	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.16e-05	0.000334	CcSEcCtD
Pemetrexed—Decreased appetite—Gabapentin—epilepsy syndrome	6.14e-05	0.000333	CcSEcCtD
Pemetrexed—Urticaria—Pregabalin—epilepsy syndrome	6.12e-05	0.000332	CcSEcCtD
Pemetrexed—Asthenia—Valproic Acid—epilepsy syndrome	6.12e-05	0.000332	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.1e-05	0.000331	CcSEcCtD
Pemetrexed—Fatigue—Gabapentin—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Pemetrexed—Abdominal pain—Pregabalin—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Pemetrexed—Body temperature increased—Pregabalin—epilepsy syndrome	6.09e-05	0.000331	CcSEcCtD
Pemetrexed—Constipation—Gabapentin—epilepsy syndrome	6.04e-05	0.000328	CcSEcCtD
Pemetrexed—Pain—Gabapentin—epilepsy syndrome	6.04e-05	0.000328	CcSEcCtD
Pemetrexed—Pruritus—Valproic Acid—epilepsy syndrome	6.03e-05	0.000327	CcSEcCtD
Pemetrexed—Oedema—Topiramate—epilepsy syndrome	5.95e-05	0.000323	CcSEcCtD
Pemetrexed—Infection—Topiramate—epilepsy syndrome	5.91e-05	0.000321	CcSEcCtD
Pemetrexed—Shock—Topiramate—epilepsy syndrome	5.85e-05	0.000317	CcSEcCtD
Pemetrexed—Diarrhoea—Valproic Acid—epilepsy syndrome	5.83e-05	0.000317	CcSEcCtD
Pemetrexed—Nervous system disorder—Topiramate—epilepsy syndrome	5.83e-05	0.000316	CcSEcCtD
Pemetrexed—Thrombocytopenia—Topiramate—epilepsy syndrome	5.82e-05	0.000316	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.78e-05	0.000314	CcSEcCtD
Pemetrexed—Skin disorder—Topiramate—epilepsy syndrome	5.78e-05	0.000313	CcSEcCtD
Pemetrexed—Hypersensitivity—Pregabalin—epilepsy syndrome	5.68e-05	0.000308	CcSEcCtD
Pemetrexed—Anorexia—Topiramate—epilepsy syndrome	5.67e-05	0.000308	CcSEcCtD
Pemetrexed—Dizziness—Valproic Acid—epilepsy syndrome	5.64e-05	0.000306	CcSEcCtD
Pemetrexed—Urticaria—Gabapentin—epilepsy syndrome	5.61e-05	0.000305	CcSEcCtD
Pemetrexed—Abdominal pain—Gabapentin—epilepsy syndrome	5.59e-05	0.000303	CcSEcCtD
Pemetrexed—Body temperature increased—Gabapentin—epilepsy syndrome	5.59e-05	0.000303	CcSEcCtD
Pemetrexed—Asthenia—Pregabalin—epilepsy syndrome	5.53e-05	0.0003	CcSEcCtD
Pemetrexed—Pruritus—Pregabalin—epilepsy syndrome	5.45e-05	0.000296	CcSEcCtD
Pemetrexed—Vomiting—Valproic Acid—epilepsy syndrome	5.42e-05	0.000294	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.42e-05	0.000294	CcSEcCtD
Pemetrexed—Rash—Valproic Acid—epilepsy syndrome	5.38e-05	0.000292	CcSEcCtD
Pemetrexed—Dermatitis—Valproic Acid—epilepsy syndrome	5.37e-05	0.000291	CcSEcCtD
Pemetrexed—Dyspnoea—Topiramate—epilepsy syndrome	5.3e-05	0.000288	CcSEcCtD
Pemetrexed—Diarrhoea—Pregabalin—epilepsy syndrome	5.27e-05	0.000286	CcSEcCtD
Pemetrexed—Dyspepsia—Topiramate—epilepsy syndrome	5.23e-05	0.000284	CcSEcCtD
Pemetrexed—Hypersensitivity—Gabapentin—epilepsy syndrome	5.21e-05	0.000283	CcSEcCtD
Pemetrexed—Decreased appetite—Topiramate—epilepsy syndrome	5.17e-05	0.00028	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.13e-05	0.000279	CcSEcCtD
Pemetrexed—Fatigue—Topiramate—epilepsy syndrome	5.13e-05	0.000278	CcSEcCtD
Pemetrexed—Dizziness—Pregabalin—epilepsy syndrome	5.1e-05	0.000277	CcSEcCtD
Pemetrexed—Constipation—Topiramate—epilepsy syndrome	5.08e-05	0.000276	CcSEcCtD
Pemetrexed—Pain—Topiramate—epilepsy syndrome	5.08e-05	0.000276	CcSEcCtD
Pemetrexed—Asthenia—Gabapentin—epilepsy syndrome	5.07e-05	0.000275	CcSEcCtD
Pemetrexed—Nausea—Valproic Acid—epilepsy syndrome	5.06e-05	0.000275	CcSEcCtD
Pemetrexed—Pruritus—Gabapentin—epilepsy syndrome	5e-05	0.000271	CcSEcCtD
Pemetrexed—Vomiting—Pregabalin—epilepsy syndrome	4.9e-05	0.000266	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.86e-05	0.000264	CcSEcCtD
Pemetrexed—Rash—Pregabalin—epilepsy syndrome	4.86e-05	0.000264	CcSEcCtD
Pemetrexed—Dermatitis—Pregabalin—epilepsy syndrome	4.85e-05	0.000263	CcSEcCtD
Pemetrexed—Diarrhoea—Gabapentin—epilepsy syndrome	4.84e-05	0.000262	CcSEcCtD
Pemetrexed—Urticaria—Topiramate—epilepsy syndrome	4.72e-05	0.000256	CcSEcCtD
Pemetrexed—Body temperature increased—Topiramate—epilepsy syndrome	4.7e-05	0.000255	CcSEcCtD
Pemetrexed—Abdominal pain—Topiramate—epilepsy syndrome	4.7e-05	0.000255	CcSEcCtD
Pemetrexed—Dizziness—Gabapentin—epilepsy syndrome	4.67e-05	0.000254	CcSEcCtD
Pemetrexed—Nausea—Pregabalin—epilepsy syndrome	4.58e-05	0.000248	CcSEcCtD
Pemetrexed—Vomiting—Gabapentin—epilepsy syndrome	4.49e-05	0.000244	CcSEcCtD
Pemetrexed—Rash—Gabapentin—epilepsy syndrome	4.46e-05	0.000242	CcSEcCtD
Pemetrexed—Dermatitis—Gabapentin—epilepsy syndrome	4.45e-05	0.000242	CcSEcCtD
Pemetrexed—Hypersensitivity—Topiramate—epilepsy syndrome	4.38e-05	0.000238	CcSEcCtD
Pemetrexed—Asthenia—Topiramate—epilepsy syndrome	4.27e-05	0.000231	CcSEcCtD
Pemetrexed—Pruritus—Topiramate—epilepsy syndrome	4.21e-05	0.000228	CcSEcCtD
Pemetrexed—Nausea—Gabapentin—epilepsy syndrome	4.2e-05	0.000228	CcSEcCtD
Pemetrexed—Diarrhoea—Topiramate—epilepsy syndrome	4.07e-05	0.000221	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—KCNJ11—epilepsy syndrome	3.94e-05	0.000296	CbGpPWpGaD
Pemetrexed—Dizziness—Topiramate—epilepsy syndrome	3.93e-05	0.000213	CcSEcCtD
Pemetrexed—DHFR—Disease—GBE1—epilepsy syndrome	3.92e-05	0.000294	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CPSF4—epilepsy syndrome	3.92e-05	0.000294	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPP1R3C—epilepsy syndrome	3.92e-05	0.000294	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	3.88e-05	0.000292	CbGpPWpGaD
Pemetrexed—GART—Metabolism—HMOX1—epilepsy syndrome	3.87e-05	0.000291	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC6A8—epilepsy syndrome	3.86e-05	0.00029	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—KCNB1—epilepsy syndrome	3.86e-05	0.00029	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PFKL—epilepsy syndrome	3.86e-05	0.00029	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CACNA2D2—epilepsy syndrome	3.86e-05	0.00029	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLCO1A2—epilepsy syndrome	3.86e-05	0.00029	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ASAH1—epilepsy syndrome	3.84e-05	0.000288	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CAT—epilepsy syndrome	3.82e-05	0.000287	CbGpPWpGaD
Pemetrexed—Vomiting—Topiramate—epilepsy syndrome	3.78e-05	0.000205	CcSEcCtD
Pemetrexed—TYMS—Metabolism—CA4—epilepsy syndrome	3.78e-05	0.000284	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—QDPR—epilepsy syndrome	3.78e-05	0.000284	CbGpPWpGaD
Pemetrexed—Rash—Topiramate—epilepsy syndrome	3.75e-05	0.000203	CcSEcCtD
Pemetrexed—Dermatitis—Topiramate—epilepsy syndrome	3.75e-05	0.000203	CcSEcCtD
Pemetrexed—DCK—Metabolism—STXBP1—epilepsy syndrome	3.73e-05	0.00028	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ABCB1—epilepsy syndrome	3.71e-05	0.000279	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NT5E—epilepsy syndrome	3.64e-05	0.000273	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALAD—epilepsy syndrome	3.64e-05	0.000273	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP2D6—epilepsy syndrome	3.61e-05	0.000271	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—NOS2—epilepsy syndrome	3.61e-05	0.000271	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—COX3—epilepsy syndrome	3.55e-05	0.000267	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.54e-05	0.000266	CbGpPWpGaD
Pemetrexed—Nausea—Topiramate—epilepsy syndrome	3.53e-05	0.000192	CcSEcCtD
Pemetrexed—DHFR—Metabolism—NEU1—epilepsy syndrome	3.53e-05	0.000265	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ATIC—epilepsy syndrome	3.53e-05	0.000265	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—UPB1—epilepsy syndrome	3.53e-05	0.000265	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.51e-05	0.000263	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CACNA1A—epilepsy syndrome	3.47e-05	0.000261	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALDH7A1—epilepsy syndrome	3.47e-05	0.000261	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GPX1—epilepsy syndrome	3.45e-05	0.000259	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ADRA2A—epilepsy syndrome	3.43e-05	0.000258	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—BCHE—epilepsy syndrome	3.42e-05	0.000257	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HSD17B4—epilepsy syndrome	3.4e-05	0.000255	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ST3GAL3—epilepsy syndrome	3.4e-05	0.000255	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.4e-05	0.000255	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	3.39e-05	0.000255	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—KCNB1—epilepsy syndrome	3.37e-05	0.000253	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CACNA2D2—epilepsy syndrome	3.37e-05	0.000253	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC6A8—epilepsy syndrome	3.37e-05	0.000253	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PFKL—epilepsy syndrome	3.37e-05	0.000253	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLCO1A2—epilepsy syndrome	3.37e-05	0.000253	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ADSL—epilepsy syndrome	3.33e-05	0.00025	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	3.31e-05	0.000249	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GBE1—epilepsy syndrome	3.28e-05	0.000246	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPP1R3C—epilepsy syndrome	3.28e-05	0.000246	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GLUL—epilepsy syndrome	3.26e-05	0.000245	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SLC2A1—epilepsy syndrome	3.26e-05	0.000245	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ST3GAL3—epilepsy syndrome	3.26e-05	0.000245	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PLCB1—epilepsy syndrome	3.23e-05	0.000242	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—TH—epilepsy syndrome	3.21e-05	0.000241	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCG2—epilepsy syndrome	3.21e-05	0.000241	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CACNA1D—epilepsy syndrome	3.2e-05	0.000241	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP2C19—epilepsy syndrome	3.13e-05	0.000235	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP11A1—epilepsy syndrome	3.11e-05	0.000234	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ASAH1—epilepsy syndrome	3.08e-05	0.000232	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—UPB1—epilepsy syndrome	3.08e-05	0.000231	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NEU1—epilepsy syndrome	3.08e-05	0.000231	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ATIC—epilepsy syndrome	3.08e-05	0.000231	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.06e-05	0.00023	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SLC2A1—epilepsy syndrome	3.03e-05	0.000228	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AGT—epilepsy syndrome	3.03e-05	0.000227	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—JUNB—epilepsy syndrome	3.01e-05	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—STXBP1—epilepsy syndrome	3e-05	0.000225	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TXNRD1—epilepsy syndrome	3e-05	0.000225	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS1—epilepsy syndrome	2.99e-05	0.000225	CbGpPWpGaD
Pemetrexed—GART—Metabolism—APOE—epilepsy syndrome	2.97e-05	0.000223	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HSD17B4—epilepsy syndrome	2.96e-05	0.000223	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—APEX1—epilepsy syndrome	2.96e-05	0.000223	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NT5E—epilepsy syndrome	2.92e-05	0.00022	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALAD—epilepsy syndrome	2.92e-05	0.00022	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AQP1—epilepsy syndrome	2.91e-05	0.000219	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	2.91e-05	0.000218	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	2.89e-05	0.000217	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPP1R3C—epilepsy syndrome	2.86e-05	0.000215	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GBE1—epilepsy syndrome	2.86e-05	0.000215	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HBEGF—epilepsy syndrome	2.85e-05	0.000214	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP2D6—epilepsy syndrome	2.81e-05	0.000211	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT3—epilepsy syndrome	2.8e-05	0.00021	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CACNA1A—epilepsy syndrome	2.79e-05	0.00021	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALDH7A1—epilepsy syndrome	2.79e-05	0.00021	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	2.76e-05	0.000207	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ADAM10—epilepsy syndrome	2.73e-05	0.000205	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ST3GAL3—epilepsy syndrome	2.73e-05	0.000205	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ASAH1—epilepsy syndrome	2.69e-05	0.000202	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—HMOX1—epilepsy syndrome	2.68e-05	0.000202	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.68e-05	0.000201	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADSL—epilepsy syndrome	2.67e-05	0.000201	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ADRA2A—epilepsy syndrome	2.67e-05	0.000201	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—BCHE—epilepsy syndrome	2.66e-05	0.0002	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	2.65e-05	0.000199	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CAT—epilepsy syndrome	2.65e-05	0.000199	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CHRM3—epilepsy syndrome	2.63e-05	0.000198	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—KCNJ11—epilepsy syndrome	2.63e-05	0.000198	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GLUL—epilepsy syndrome	2.62e-05	0.000197	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—STXBP1—epilepsy syndrome	2.62e-05	0.000197	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—APEX1—epilepsy syndrome	2.59e-05	0.000194	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ABCB1—epilepsy syndrome	2.57e-05	0.000193	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CACNA1D—epilepsy syndrome	2.57e-05	0.000193	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.56e-05	0.000193	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDC42—epilepsy syndrome	2.55e-05	0.000192	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NT5E—epilepsy syndrome	2.55e-05	0.000192	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALAD—epilepsy syndrome	2.55e-05	0.000192	CbGpPWpGaD
Pemetrexed—GART—Metabolism—POMC—epilepsy syndrome	2.55e-05	0.000191	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SLC2A1—epilepsy syndrome	2.54e-05	0.000191	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PLCB1—epilepsy syndrome	2.51e-05	0.000189	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—TH—epilepsy syndrome	2.5e-05	0.000188	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	2.49e-05	0.000187	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDH7A1—epilepsy syndrome	2.43e-05	0.000183	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CACNA1A—epilepsy syndrome	2.43e-05	0.000183	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TXNRD1—epilepsy syndrome	2.41e-05	0.000181	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GPX1—epilepsy syndrome	2.39e-05	0.00018	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—JUN—epilepsy syndrome	2.39e-05	0.00018	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ST3GAL3—epilepsy syndrome	2.38e-05	0.000179	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EIF2AK2—epilepsy syndrome	2.37e-05	0.000178	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—H2AFX—epilepsy syndrome	2.37e-05	0.000178	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HES1—epilepsy syndrome	2.34e-05	0.000176	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AQP1—epilepsy syndrome	2.34e-05	0.000176	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ADSL—epilepsy syndrome	2.33e-05	0.000175	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ALB—epilepsy syndrome	2.32e-05	0.000175	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	2.31e-05	0.000174	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GLUL—epilepsy syndrome	2.29e-05	0.000172	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FYN—epilepsy syndrome	2.27e-05	0.000171	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—H2AFX—epilepsy syndrome	2.27e-05	0.00017	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CACNA1D—epilepsy syndrome	2.25e-05	0.000169	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.23e-05	0.000168	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPIA—epilepsy syndrome	2.2e-05	0.000165	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—YWHAZ—epilepsy syndrome	2.19e-05	0.000164	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.18e-05	0.000163	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCG2—epilepsy syndrome	2.14e-05	0.000161	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.12e-05	0.00016	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—KCNJ11—epilepsy syndrome	2.11e-05	0.000159	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CHRM3—epilepsy syndrome	2.11e-05	0.000159	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	2.11e-05	0.000158	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CCR5—epilepsy syndrome	2.1e-05	0.000158	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TXNRD1—epilepsy syndrome	2.1e-05	0.000158	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AGT—epilepsy syndrome	2.1e-05	0.000158	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2C19—epilepsy syndrome	2.09e-05	0.000157	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—HMOX1—epilepsy syndrome	2.09e-05	0.000157	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP11A1—epilepsy syndrome	2.08e-05	0.000156	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—H2AFX—epilepsy syndrome	2.07e-05	0.000155	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAT—epilepsy syndrome	2.06e-05	0.000155	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—epilepsy syndrome	2.06e-05	0.000154	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AQP1—epilepsy syndrome	2.04e-05	0.000153	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—epilepsy syndrome	2.03e-05	0.000153	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCB1—epilepsy syndrome	2.01e-05	0.000151	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TSC2—epilepsy syndrome	1.96e-05	0.000147	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—ATM—epilepsy syndrome	1.93e-05	0.000145	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—epilepsy syndrome	1.91e-05	0.000144	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PRKCB—epilepsy syndrome	1.89e-05	0.000142	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2D6—epilepsy syndrome	1.87e-05	0.000141	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GPX1—epilepsy syndrome	1.86e-05	0.00014	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.86e-05	0.00014	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CHRM3—epilepsy syndrome	1.84e-05	0.000139	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—KCNJ11—epilepsy syndrome	1.84e-05	0.000139	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	1.84e-05	0.000138	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6ST—epilepsy syndrome	1.8e-05	0.000135	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ADRA2A—epilepsy syndrome	1.78e-05	0.000134	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS2—epilepsy syndrome	1.78e-05	0.000134	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—BCHE—epilepsy syndrome	1.78e-05	0.000133	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—POMC—epilepsy syndrome	1.77e-05	0.000133	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCG2—epilepsy syndrome	1.72e-05	0.000129	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A1—epilepsy syndrome	1.7e-05	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—ATM—epilepsy syndrome	1.68e-05	0.000126	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2C19—epilepsy syndrome	1.68e-05	0.000126	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PLCB1—epilepsy syndrome	1.68e-05	0.000126	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TH—epilepsy syndrome	1.67e-05	0.000126	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP11A1—epilepsy syndrome	1.67e-05	0.000125	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PRKCB—epilepsy syndrome	1.65e-05	0.000124	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AGT—epilepsy syndrome	1.64e-05	0.000123	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A1—epilepsy syndrome	1.63e-05	0.000122	CbGpPWpGaD
Pemetrexed—DHFR—Disease—JUNB—epilepsy syndrome	1.61e-05	0.000121	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—epilepsy syndrome	1.61e-05	0.000121	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS1—epilepsy syndrome	1.6e-05	0.00012	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—epilepsy syndrome	1.6e-05	0.00012	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HBEGF—epilepsy syndrome	1.53e-05	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2D6—epilepsy syndrome	1.51e-05	0.000113	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCG2—epilepsy syndrome	1.5e-05	0.000113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT3—epilepsy syndrome	1.5e-05	0.000113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ADAM10—epilepsy syndrome	1.47e-05	0.00011	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2C19—epilepsy syndrome	1.47e-05	0.00011	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP11A1—epilepsy syndrome	1.46e-05	0.000109	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGF2—epilepsy syndrome	1.45e-05	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADRA2A—epilepsy syndrome	1.43e-05	0.000108	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—epilepsy syndrome	1.43e-05	0.000107	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—epilepsy syndrome	1.41e-05	0.000106	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—epilepsy syndrome	1.39e-05	0.000105	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.39e-05	0.000104	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POMC—epilepsy syndrome	1.38e-05	0.000103	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAT—epilepsy syndrome	1.38e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDC42—epilepsy syndrome	1.37e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A1—epilepsy syndrome	1.36e-05	0.000102	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLCB1—epilepsy syndrome	1.35e-05	0.000101	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TH—epilepsy syndrome	1.34e-05	0.000101	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCB1—epilepsy syndrome	1.34e-05	0.000101	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTOR—epilepsy syndrome	1.32e-05	9.94e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2D6—epilepsy syndrome	1.31e-05	9.87e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—epilepsy syndrome	1.31e-05	9.85e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—epilepsy syndrome	1.25e-05	9.43e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—epilepsy syndrome	1.25e-05	9.42e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ADRA2A—epilepsy syndrome	1.25e-05	9.4e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—epilepsy syndrome	1.25e-05	9.36e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—epilepsy syndrome	1.24e-05	9.35e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FYN—epilepsy syndrome	1.22e-05	9.16e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—H2AFX—epilepsy syndrome	1.22e-05	9.13e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A1—epilepsy syndrome	1.19e-05	8.93e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLCB1—epilepsy syndrome	1.18e-05	8.83e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—YWHAZ—epilepsy syndrome	1.17e-05	8.81e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TH—epilepsy syndrome	1.17e-05	8.8e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CCR5—epilepsy syndrome	1.13e-05	8.47e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—epilepsy syndrome	1.12e-05	8.42e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAT—epilepsy syndrome	1.11e-05	8.31e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—epilepsy syndrome	1.1e-05	8.25e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AGT—epilepsy syndrome	1.09e-05	8.2e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCB1—epilepsy syndrome	1.08e-05	8.08e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—epilepsy syndrome	1.07e-05	8.03e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SRC—epilepsy syndrome	1.06e-05	7.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TSC2—epilepsy syndrome	1.05e-05	7.87e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—epilepsy syndrome	1.03e-05	7.71e-05	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—epilepsy syndrome	1.02e-05	7.68e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—epilepsy syndrome	1e-05	7.51e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—epilepsy syndrome	9.78e-06	7.35e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAT—epilepsy syndrome	9.65e-06	7.25e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6ST—epilepsy syndrome	9.64e-06	7.24e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—epilepsy syndrome	9.56e-06	7.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCB1—epilepsy syndrome	9.39e-06	7.05e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—POMC—epilepsy syndrome	9.18e-06	6.9e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AGT—epilepsy syndrome	8.77e-06	6.59e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—epilepsy syndrome	8.73e-06	6.55e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—epilepsy syndrome	8.59e-06	6.45e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—epilepsy syndrome	8.37e-06	6.29e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF2—epilepsy syndrome	7.79e-06	5.85e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AGT—epilepsy syndrome	7.65e-06	5.75e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—epilepsy syndrome	7.5e-06	5.63e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POMC—epilepsy syndrome	7.38e-06	5.54e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—epilepsy syndrome	7.33e-06	5.5e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTOR—epilepsy syndrome	7.09e-06	5.33e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—epilepsy syndrome	7.08e-06	5.32e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—epilepsy syndrome	7.03e-06	5.28e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—epilepsy syndrome	6.73e-06	5.05e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—epilepsy syndrome	6.59e-06	4.95e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POMC—epilepsy syndrome	6.44e-06	4.84e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—epilepsy syndrome	5.89e-06	4.42e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—epilepsy syndrome	5.87e-06	4.41e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SRC—epilepsy syndrome	5.69e-06	4.27e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—epilepsy syndrome	5.52e-06	4.14e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—epilepsy syndrome	5.14e-06	3.86e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—epilepsy syndrome	3.68e-06	2.77e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—epilepsy syndrome	3.53e-06	2.65e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—epilepsy syndrome	2.96e-06	2.22e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—epilepsy syndrome	2.58e-06	1.94e-05	CbGpPWpGaD
